The National Clinical Trials Network (NCTN) supported by the National Cancer Institute (NCI) has played an integral role in cancer research and in establishing the standard of care for cancer patients for more than 50 years. Formerly known as the NCI Clinical Trials Cooperative Group Program, the NCTN is comprised of more than 2,100 institutions and 14,000 investigators, who enroll more than 20,000 cancer patients in clinical trials each year across the United States and internationally.
Table of Contents |
skim chapter | |
---|---|---|
Front Matter | i-xviii | |
Implementing a National Cancer Clinical Trials System for the 21st Century | 1-74 | |
References | 75-78 | |
Acronyms | 79-82 | |
Appendix A: Workshop Statement of Task and Agenda | 83-88 | |
Appendix B: Executive Summary of *A National Cancer Clinical Trials System for the 21st Century* | 89-92 |
The National Academies Press and the Transportation Research Board have partnered with Copyright Clearance Center to offer a variety of options for reusing our content. You may request permission to:
For most Academic and Educational uses no royalties will be charged although you are required to obtain a license and comply with the license terms and conditions.
For information on how to request permission to translate our work and for any other rights related query please click here.
For questions about using the Copyright.com service, please contact:
Copyright Clearance Center
22 Rosewood Drive
Danvers, MA 01923
Tel (toll free): 855/239-3415 (select option 1)
E-mail: info@copyright.com
Web: https://www.copyright.com
Loading stats for Implementing a National Cancer Clinical Trials System for the 21st Century: Second Workshop Summary...